Ted White
Net Worth

Last updated:

What is Ted White net worth?

The estimated net worth of Mr. Ted White is at least $7,065,580 as of 27 Aug 2024. He owns shares worth $1,321,718 as insider, has earned $662,912 from insider trading and has received compensation worth at least $5,080,950 in Verrica Pharmaceuticals Inc..

What is the salary of Ted White?

Mr. Ted White salary is $725,850 per year as Pres, Chief Executive Officer & Director in Verrica Pharmaceuticals Inc..

How old is Ted White?

Mr. Ted White is 60 years old, born in 1965.

What stocks does Ted White currently own?

As insider, Mr. Ted White owns shares in one company:

Company Title Shares Price per share Total value
Verrica Pharmaceuticals Inc. (VRCA) Pres, Chief Executive Officer & Director 215,967 $6.12 $1,321,718

What does Verrica Pharmaceuticals Inc. do?

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.

Ted White insider trading

Verrica Pharmaceuticals Inc.

Mr. Ted White has made 7 insider trades between 2018-2024, according to the Form 4 filled with the SEC. Most recently he sold 9,021 units of VRCA stock worth $22,192 on 27 Aug 2024.

The largest trade he's ever made was exercising 50,677 units of VRCA stock on 24 Jul 2023. As of 27 Aug 2024 he still owns at least 215,967 units of VRCA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 9,021 $2.46 $22,192
Sale
Common Stock 24,979 $2.66 $66,444
Sale
Common Stock 154 $6.98 $1,075
Sale
Common Stock 32,469 $7.06 $229,231
Sale
Common Stock 11,558 $2.97 $34,327
Sale
Common Stock 22,141 $2.93 $64,873
Sale
Common Stock 50,677 $4.83 $244,770
Purchase
Common Stock 23,809 $2.1 $49,999
Purchase
Common Stock 4,000 $9.95 $39,800
Purchase
Common Stock 10,661 $6.28 $66,951
Purchase
Common Stock 300 N/A N/A
Purchase
Common Stock 600 N/A N/A
Purchase
Common Stock 1,905 N/A N/A
Purchase
Common Stock 4,500 N/A N/A

Verrica Pharmaceuticals key executives

Verrica Pharmaceuticals Inc. executives and other stock owners filed with the SEC: